Skip to main content
UniHealth

Doctor search

William F Fearon, MD

Cardiovascular Disease (Cardiology) · Stanford

NPI 1770671455

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
1 carrier
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

12 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fearon’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence A54553 · Current

Licensed to practise in California · since 1995 · expires 2029-01-31 · Columbia University College of Physicians and Surgeons.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$100,892

Medicare paid this office $100,892 for 353 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Replacement of aortic valve through the skin and femoral artery68$42,101$619
Insertion of tube in coronary artery for diagnosis with review by radiologist87$14,455$166
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch25$12,157$419
Short return visit (20+ min)134$7,505$51
New patient visit (45+ min)59$6,437$109
See all 10 services
Every Original Medicare service billed
Replacement of aortic valve through the skin and femoral artery68$42,101$619
Insertion of tube in coronary artery for diagnosis with review by radiologist87$14,455$166
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch25$12,157$419
Short return visit (20+ min)134$7,505$51
New patient visit (45+ min)59$6,437$109
Return visit (30+ min)29$2,522$84
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel26$2,043$79
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel31$1,858$60
Short return visit (20+ min)18$1,502$79
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes82$860$10

Procedures Medicare counted

Procedure volume Medicare published
Coronary angioplasty and stenting44More than 78% of doctors who do this

Who their Medicare patients are

353 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 17% · Women 28% · Also on Medicaid 22% · Health risk score 2.32. Above the middle of the specialty; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Chronic kidney disease 50% · Heart failure 47% · Diabetes 43% · Atrial fibrillation 37% · Cancer 20% · Depression 15% · COPD 13% · Stroke 11% · Dementia 7%.

The office billed $1,483,283, Medicare allowed $129,866 and paid $100,892; for 649 services of 29 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024353649752.32$1,483,283$100,892
2023343668761.78$1,557,759$114,006
2022374699751.97$1,676,616$127,048
2021388741751.95$1,645,809$128,318
2020463949742.25$2,538,974$168,112
20196561,291752.14$3,049,944$223,782
20186721,286742.33$2,837,718$224,170
20178531,540752.14$3,011,382$240,816
20167051,116762.03$2,711,955$228,465
2015451680762.20$1,925,738$166,269
2014530849742.31$2,343,439$207,849
2013544901762.09$1,934,975$182,267

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Replacement of aortic valve through the skin and femoral artery85$54,455$641
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch22$11,974$428
Insertion of tube in coronary artery for diagnosis with review by radiologist57$8,489$149
Short return visit (20+ min)125$7,886$54
New patient visit (45+ min)68$7,848$115
Return visit (30+ min)54$4,562$79
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel29$2,440$81
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel20$1,249$62
Heart rhythm review and interpretation of continous external ekg over 8-15 days16$359$22
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito67$327$5
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes13$143$11

2022: 10 services

Original Medicare services billed in 2022
Replacement of aortic valve through the skin and femoral artery94$61,068$650
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch26$14,184$458
Insertion of tube in coronary artery for diagnosis with review by radiologist63$11,608$184
New patient visit (45+ min)80$9,566$120
Short return visit (20+ min)124$7,288$52
Return visit (30+ min)62$5,318$83
Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist14$1,934$138
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel22$1,902$83
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel23$1,454$63
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito90$456$5

2021: 13 services

Original Medicare services billed in 2021
Replacement of aortic valve through the skin and femoral artery81$53,589$662
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch27$13,904$434
Insertion of tube in coronary artery for diagnosis with review by radiologist65$11,354$175
Short return visit (20+ min)189$11,053$52
New patient visit (45+ min)85$10,285$121
Insertion of tube in bypass graft for diagnosis with review by radiologist13$2,807$216
Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist15$1,959$131
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel21$1,768$84
Return visit (30+ min)16$1,361$85
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel16$1,031$64
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes74$883$11
Heart rhythm review and interpretation of continous external ekg over 8-15 days21$534$24
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito16$78$5

2020: 11 services

Original Medicare services billed in 2020
Replacement of aortic valve through the skin and femoral artery105$70,640$673
Insertion of tube in coronary artery for diagnosis with review by radiologist133$24,095$178
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch38$20,715$460
New patient visit (45+ min)87$9,518$109
Short return visit (20+ min)170$7,793$41
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist16$4,214$263
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel34$2,957$84
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes155$1,821$11
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel24$1,598$67
New patient visit (30+ min)12$771$64
Review and interpretation of external ekg recording for more than 48 hours up to 21 days19$471$24

2019: 15 services

Original Medicare services billed in 2019
Replacement of aortic valve through the skin and femoral artery128$93,519$731
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch66$35,879$438
Insertion of tube in coronary artery for diagnosis with review by radiologist170$27,594$160
New patient visit (45+ min)115$12,550$109
Short return visit (20+ min)178$8,330$40
Biopsy of heart muscle26$5,126$177
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist19$4,545$239
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel45$3,965$84
Insertion of tube in bypass graft for diagnosis with review by radiologist18$2,961$164
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel37$2,544$69
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes172$1,985$11
Insertion of tube in right heart chambers for measurement22$1,724$72
Long return visit (40+ min)12$1,212$101
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only104$971$8
Review and interpretation of external ekg recording for more than 48 hours up to 21 days12$294$25

2018: 14 services

Original Medicare services billed in 2018
Replacement of aortic valve through the skin and femoral artery134$96,996$724
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch66$33,298$450
Insertion of tube in coronary artery for diagnosis with review by radiologist139$23,594$170
New patient visit (45+ min)100$10,554$106
Short return visit (20+ min)195$8,772$38
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist23$5,962$259
Biopsy of heart muscle20$5,385$174
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel36$2,959$82
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel34$2,724$80
Insertion of tube in bypass graft for diagnosis with review by radiologist15$2,670$178
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes195$2,184$11
Insertion of tube in right heart chambers for measurement23$1,975$68
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only119$1,032$8
Review and interpretation of external ekg recording for more than 48 hours up to 21 days13$319$25

2017: 14 services

Original Medicare services billed in 2017
Replacement of aortic valve through the skin and femoral artery147$107,547$727
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch55$26,850$420
Insertion of tube in coronary artery for diagnosis with review by radiologist136$25,247$180
New patient visit (45+ min)106$11,370$107
Short return visit (20+ min)182$8,309$38
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist30$7,720$257
Biopsy of heart muscle26$6,535$177
Insertion of tube in bypass graft for diagnosis with review by radiologist17$3,398$189
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel41$3,388$83
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only280$2,649$8
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes220$2,531$11
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel29$2,236$77
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel15$1,061$66
New patient visit (30+ min)16$1,018$64

2016: 18 services

Original Medicare services billed in 2016
Replacement of aortic valve through the skin and femoral artery133$97,257$726
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch47$24,746$442
Insertion of tube in coronary artery for diagnosis with review by radiologist117$21,524$181
Balloon dilation repair of aortic valve11$13,921$1,160
New patient visit (45+ min)91$10,273$113
Short return visit (20+ min)186$8,709$40
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist25$6,346$254
Insertion of tube in bypass graft for diagnosis with review by radiologist17$3,931$218
Biopsy of heart muscle15$3,899$186
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel38$3,149$81
Initial hospital observation care per day, typically 50 minutes20$2,417$121
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes17$2,187$121
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel22$1,817$83
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes15$1,672$64
New patient visit (30+ min)22$1,245$57
Hospital discharge day management, 30 minutes or less15$1,118$66
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only128$1,047$7
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel11$894$60

2015: 12 services

Original Medicare services billed in 2015
Replacement of aortic valve by through femoral artery73$57,836$792
Insertion of tube in coronary artery for diagnosis with review by radiologist74$14,905$201
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch26$13,390$446
Replacement of aortic valve through the skin and femoral artery14$10,205$729
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist38$10,203$268
New patient visit (45+ min)83$9,300$112
Short return visit (20+ min)167$7,297$37
Biopsy of heart muscle22$6,029$188
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel18$1,498$83
Insertion of tube in right heart chambers for measurement15$1,245$83
New patient visit (30+ min)19$1,119$59
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel12$1,000$83

2014: 12 services

Original Medicare services billed in 2014
Replacement of aortic valve by through femoral artery90$71,462$794
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch39$21,510$478
Insertion of tube in coronary artery for diagnosis with review by radiologist91$16,735$184
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist52$14,186$273
Biopsy of heart muscle21$9,508$190
Short return visit (20+ min)186$8,781$39
New patient visit (45+ min)77$8,629$112
Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist11$3,558$323
New patient visit (30+ min)45$2,729$61
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel26$2,069$80
Insertion of tube in right heart chambers for measurement17$1,636$86
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel13$1,034$80

2013: 19 services

Original Medicare services billed in 2013
Replacement of aortic valve by through femoral artery48$36,911$769
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch35$18,575$464
Replacement of aortic valve with prosthetic valve18$16,692$927
Balloon dilation repair of aortic valve12$13,668$1,139
Insertion of tube in coronary artery for diagnosis with review by radiologist71$12,386$172
Implantation prosthetic aortic heart valve via catheter through chest12$11,084$924
New patient visit (45+ min)98$10,686$109
Short return visit (20+ min)195$9,932$39
Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist37$9,801$265
Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel16$9,544$530
Insertion of tube in right heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist15$4,088$273
Insertion of tube in bypass graft for diagnosis with review by radiologist19$3,889$194
Biopsy of heart muscle13$3,010$167
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel29$2,235$77
New patient visit (30+ min)29$1,738$60
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel17$1,389$77
Return visit (30+ min)14$884$63
Review and interpretation of external ekg recording for more than 48 hours up to 21 days32$726$22
Short return visit17$325$19

Medicaid work

$414 in 2020

Medicaid paid $414 for 13 billed services this clinician did in 2020, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2020
Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older13$414
Medicaid work by year
202013113$414
201984173$1,155
201885169$983
See the largest Medicaid services in earlier years

2019

Largest Medicaid services in 2019
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only84$1,155

2018

Largest Medicaid services in 2018
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only85$983

Drugs they prescribed that Part D paid

$176,937

Pharmacies billed $176,937 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,100) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

975 generic and 125 brand-name prescriptions · $176,937 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Eliquis56$75,929$1,356
Repatha Sureclick15$22,341$1,489
Brilinta13$14,671$1,129
Ranolazine Er12$2,574$214
Rosuvastatin158$2,393$15
See all 19 drugs
Every Part D drug this clinician prescribed
Eliquis56$75,929$1,356
Repatha Sureclick15$22,341$1,489
Brilinta13$14,671$1,129
Ranolazine Er12$2,574$214
Rosuvastatin158$2,393$15
Atorvastatin142$2,149$15
Ezetimibe64$1,990$31
Prasugrel16$1,459$91
Clopidogrel95$1,359$14
Metoprolol51$921$18
Amlodipine Besylate77$796$10
Isosorbide Mononitrate Er44$669$15
Carvedilol62$668$11
Nitroglycerin25$478$19
Losartan48$404$8
Lisinopril63$393$6
Furosemide22$155$7
Hydrochlorothiazide32$71$2
Metoprolol14$71$5

Year by year

Part D prescribing by year
20241,1001670% (0)11%$176,937
20231,0391600% (0)15%$210,617
20221,1411630% (0)11%$159,248
20211,1081680% (0)13%$151,044
20201,1611750% (0)12%$139,451
20191,2812070% (0)12%$136,420
20181,2871800% (0)10%$107,139
20171,3821710% (0)17%$100,318
20161,491192NoneNone$112,527
20151,3061640% (0)None$95,279
20141,2661480% (0)None$94,315
2013997141None32%$66,885

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 20 drugs

Part D drugs prescribed in 2023
Eliquis66$88,102$1,335
Repatha Sureclick25$31,291$1,252
Brilinta13$16,377$1,260
Praluent13$7,993$615
Rosuvastatin129$5,128$40
Atorvastatin142$2,238$16
Clopidogrel74$1,231$17
Ezetimibe38$1,150$30
Metoprolol52$1,098$21
Prasugrel12$1,020$85
Lisinopril71$885$12
Isosorbide Mononitrate Er39$850$22
Losartan32$761$24
Amlodipine Besylate72$694$10
Carvedilol59$669$11
Nitroglycerin17$471$28
Furosemide23$210$9
Atenolol12$82$7
Hydrochlorothiazide22$59$3
Metoprolol16$54$3

2022: 22 drugs

Part D drugs prescribed in 2022
Eliquis42$49,508$1,179
Brilinta13$15,837$1,218
Repatha Sureclick14$15,114$1,080
Praluent17$12,528$737
Rosuvastatin133$5,152$39
Ezetimibe57$5,056$89
Atorvastatin168$2,453$15
Clopidogrel93$1,373$15
Metoprolol78$1,355$17
Prasugrel13$1,353$104
Potassium Chloride11$982$89
Carvedilol46$945$21
Lisinopril84$843$10
Isosorbide Mononitrate Er29$795$27
Losartan35$661$19
Amlodipine Besylate69$626$9
Nitroglycerin18$321$18
Furosemide19$140$7
Atenolol19$121$6
Metoprolol19$93$5
Hydrochlorothiazide26$78$3
Prednisone18$42$2

2021: 20 drugs

Part D drugs prescribed in 2021
Eliquis46$58,137$1,264
Repatha Sureclick22$19,497$886
Brilinta14$16,155$1,154
Praluent18$13,513$751
Repatha Pushtronex13$7,105$547
Rosuvastatin130$4,957$38
Ezetimibe47$2,788$59
Atorvastatin150$2,412$16
Clopidogrel115$1,471$13
Carvedilol51$994$19
Metoprolol53$837$16
Losartan29$808$28
Amlodipine Besylate77$715$9
Lisinopril82$618$8
Nitroglycerin22$435$20
Isosorbide Mononitrate Er13$397$31
Hydrochlorothiazide24$220$9
Atenolol26$165$6
Metoprolol18$124$7
Furosemide12$113$9

2020: 21 drugs

Part D drugs prescribed in 2020
Eliquis53$59,776$1,128
Brilinta19$14,434$760
Praluent17$13,865$816
Repatha Sureclick12$11,475$956
Rosuvastatin108$6,050$56
Atorvastatin159$2,524$16
Clopidogrel195$2,187$11
Ezetimibe35$1,841$53
Metoprolol49$1,096$22
Carvedilol55$708$13
Losartan35$657$19
Amlodipine Besylate75$528$7
Lisinopril84$485$6
Isosorbide Mononitrate Er11$297$27
Pravastatin13$274$21
Metoprolol23$236$10
Losartan-Hydrochlorothiazide15$212$14
Atenolol29$201$7
Nitroglycerin20$196$10
Hydrochlorothiazide23$137$6
Furosemide16$116$7

2019: 21 drugs

Part D drugs prescribed in 2019
Eliquis56$52,486$937
Xarelto15$18,440$1,229
Praluent20$17,296$865
Rosuvastatin120$8,893$74
Atorvastatin175$3,738$21
Ezetimibe52$2,660$51
Clopidogrel168$2,243$13
Metoprolol73$2,096$29
Carvedilol64$928$15
Lisinopril82$742$9
Amlodipine Besylate77$579$8
Pravastatin25$501$20
Potassium Chloride15$456$30
Losartan46$436$9
Isosorbide Mononitrate Er15$344$23
Nitroglycerin18$257$14
Metoprolol22$239$11
Furosemide33$217$7
Atenolol28$195$7
Hydrochlorothiazide17$119$7
Prednisone15$34$2

2018: 24 drugs

Part D drugs prescribed in 2018
Eliquis54$40,778$755
Xarelto17$18,147$1,067
Rosuvastatin96$6,880$72
Ezetimibe59$6,516$110
Atorvastatin188$3,905$21
Dexilant12$3,332$278
Clopidogrel184$2,477$13
Metoprolol63$2,002$32
Carvedilol79$909$12
Isosorbide Mononitrate Er18$518$29
Amlodipine Besylate78$488$6
Lisinopril64$486$8
Losartan49$414$8
Pravastatin22$411$19
Nitroglycerin11$350$32
Potassium Chloride12$320$27
Furosemide28$284$10
Atenolol30$206$7
Hydrochlorothiazide28$200$7
Triamterene-Hydrochlorothiazid11$191$17
Warfarin11$177$16
Spironolactone12$130$11
Metoprolol16$122$8
Simvastatin11$71$6

2017: 28 drugs

Part D drugs prescribed in 2017
Eliquis31$20,086$648
Xarelto22$16,161$735
Zetia24$12,781$533
Rosuvastatin92$8,743$95
Atorvastatin196$3,910$20
Ezetimibe18$3,032$168
Metoprolol91$2,843$31
Clopidogrel142$2,508$18
Carvedilol80$800$10
Isosorbide Mononitrate Er22$774$35
Nitroglycerin13$598$46
Furosemide70$596$9
Amlodipine Besylate77$548$7
Losartan58$547$9
Potassium Chloride12$498$41
Lisinopril64$455$7
Nitrostat11$435$40
Valsartan14$428$31
Pravastatin30$345$12
Warfarin18$340$19
Ramipril14$241$17
Triamterene-Hydrochlorothiazid13$224$17
Hydrochlorothiazide32$192$6
Metoprolol19$156$8
Spironolactone20$124$6
Atenolol28$83$3
Simvastatin12$82$7
Prednisone14$35$3

2016: 26 drugs

Part D drugs prescribed in 2016
Crestor52$26,516$510
Zetia45$18,337$407
Eliquis34$17,537$516
Brilinta17$8,810$518
Atorvastatin218$4,589$21
Rosuvastatin26$3,976$153
Metoprolol109$2,920$27
Clopidogrel150$2,723$18
Isosorbide Mononitrate Er38$1,246$33
Carvedilol98$904$9
Nitrostat21$785$37
Amlodipine Besylate86$546$6
Lisinopril59$501$8
Valsartan-Hydrochlorothiazide19$427$22
Losartan39$424$11
Furosemide62$395$6
Pravastatin28$342$12
Valsartan12$333$28
Hydralazine22$307$14
Spironolactone30$262$9
Warfarin27$228$8
Metoprolol17$223$13
Hydrochlorothiazide41$205$5
Triamterene-Hydrochlorothiazid16$181$11
Atenolol37$156$4
Prednisone11$30$3

2015: 23 drugs

Part D drugs prescribed in 2015
Crestor58$23,021$397
Eliquis39$17,291$443
Zetia43$12,451$290
Atorvastatin162$3,812$24
Diovan17$3,570$210
Clopidogrel145$1,844$13
Metoprolol56$1,746$31
Eplerenone15$1,311$87
Carvedilol109$1,054$10
Isosorbide Mononitrate Er19$703$37
Losartan68$629$9
Lisinopril79$563$7
Nitrostat16$517$32
Pravastatin17$376$22
Amlodipine Besylate69$339$5
Furosemide55$338$6
Spironolactone30$240$8
Hydrochlorothiazide46$227$5
Warfarin15$211$14
Simvastatin18$149$8
Atenolol32$124$4
Metoprolol11$107$10
Prednisone12$33$3

2014: 25 drugs

Part D drugs prescribed in 2014
Crestor67$21,561$322
Zetia45$12,434$276
Niaspan28$6,381$228
Xarelto13$5,963$459
Atorvastatin184$4,741$26
Diovan13$3,438$264
Vytorin13$3,131$241
Clopidogrel140$3,100$22
Metoprolol50$2,216$44
Carvedilol116$1,210$10
Eplerenone13$1,177$91
Pravastatin20$789$39
Lisinopril65$605$9
Losartan44$526$12
Nitrostat19$444$23
Amlodipine Besylate51$436$9
Isosorbide Mononitrate Er11$343$31
Simvastatin23$315$14
Furosemide51$310$6
Hydrochlorothiazide42$258$6
Spironolactone28$253$9
Warfarin17$219$13
Metoprolol15$214$14
Atenolol20$112$6
Zolpidem11$52$5

2013: 21 drugs

Part D drugs prescribed in 2013
Crestor52$12,261$236
Niaspan36$10,903$303
Zetia31$6,706$216
Clopidogrel157$6,317$40
Atorvastatin131$6,065$46
Vytorin11$2,970$270
Metoprolol39$2,291$59
Carvedilol59$830$14
Losartan45$706$16
Simvastatin38$514$14
Lisinopril51$452$9
Amlodipine Besylate37$353$10
Pravastatin12$314$26
Hydrochlorothiazide41$297$7
Metoprolol21$263$13
Warfarin14$194$14
Furosemide41$169$4
Nitrostat11$139$13
Spironolactone11$104$9
Atenolol21$100$5
Zolpidem11$47$4

Money from drug and device companies

$2,922 in 2025

Industry payments by year
202569$2,100$2,922
2024612None$9,532
2023626$12,500$16,218
2022512$5,070$5,738
202158$2,563$3,480
202046None$435
2019716$17,106$30,047

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

  • CathWorks, Inc.

    Published ownership

    $228,643

    Held by this doctor · 2023 · Options Exercised. · amount invested $24,568

Published ownership or investment in a drug or device company. This is not proof that care is biased.

A payment is not proof that care is biased.

Payments by company
Edwards LifesciencesNone$2,124
2 payments
  • Consulting · 2025-07-10 · $2,100
  • Meals · 2025-03-29 · $24
CathWorksFfrangio$302
1 payment
  • Meals for Ffrangio · 2025-10-27 · $302
MedtronicOnyx Frontier$231
3 payments
  • Meals for Corevalve Evolut R · 2025-03-09 · $40
  • Meals for Onyx Frontier · 2025-03-09 · $10
  • Meals for Onyx Frontier · 2025-02-06 · $181
Abbott LaboratoriesUltreon$204
1 payment
  • Meals for Ultreon · 2025-11-13 · $204
Boston ScientificGeneral - Therapies$34
1 payment
  • Meals for General - Therapies · 2025-03-08 · $34
HeartflowFfrct$26
1 payment
  • Meals for Ffrct · 2025-03-30 · $26
See all 9 published payments
Every published payment
Abbott LaboratoriesMeals · 2025-11-13Ultreon$204
CathWorksMeals · 2025-10-27Ffrangio$302
Edwards LifesciencesConsulting · 2025-07-10None$2,100
HeartflowMeals · 2025-03-30Ffrct$26
Edwards LifesciencesMeals · 2025-03-29None$24
MedtronicMeals · 2025-03-09Corevalve Evolut R$40
MedtronicMeals · 2025-03-09Onyx Frontier$10
Boston ScientificMeals · 2025-03-08General - Therapies$34
MedtronicMeals · 2025-02-06Onyx Frontier$181
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $9,532

Payments by company in 2024
CathWorksFfrangio$8,573
1 payment
  • Travel for Ffrangio · 2024-07-02 · $8,573
MedtronicCorevalve Evolut R$407
5 payments
  • Meals for Corevalve Evolut R · 2024-10-29 · $39
  • Meals for Onyx Frontier · 2024-10-29 · $57
  • Meals for Corevalve Evolut R · 2024-09-17 · $173
  • Meals for Corevalve Evolut R · 2024-03-09 · $118
  • Meals for Onyx Frontier · 2024-03-09 · $20
Edwards LifesciencesSapien 3 Ultra Resilia$222
1 payment
  • Meals for Sapien 3 Ultra Resilia · 2024-10-04 · $222
Abbott LaboratoriesDragonfly Opstar$154
2 payments
  • Meals for Dragonfly Opstar · 2024-10-28 · $96
  • Meals for Coroflow · 2024-05-03 · $59
Boston ScientificNone$141
1 payment
  • Meals · 2024-10-27 · $141
AbiomedImpella$35
1 payment
  • Meals for Impella · 2024-11-05 · $35

2023: $16,218

Payments by company in 2023
CathWorksFfrangio$12,455
8 payments
  • Travel for Ffrangio · 2023-12-31 · $707
  • Travel for Ffrangio · 2023-12-08 · $1,162
  • Meals for Ffrangio · 2023-11-30 · $130
  • Travel for Ffrangio · 2023-11-01 · $464
  • Consulting for Ffrangio · 2023-06-01 · $2,500
  • Meals for Ffrangio · 2023-04-30 · $242
  • Consulting for Ffrangio · 2023-04-01 · $2,000
  • Consulting for Ffrangio · 2023-03-01 · $5,250
SpectraWAVEHypervue Imaging System$3,268
3 payments
  • Consulting for Hypervue Imaging System · 2023-12-01 · $2,750
  • Meals for Hypervue Imaging System · 2023-10-22 · $361
  • Meals for Hypervue Imaging System · 2023-09-28 · $156
MedtronicCorevalve Evolut R$229
4 payments
  • Meals for Onyx Frontier · 2023-10-25 · $23
  • Meals for Onyx Frontier · 2023-05-20 · $61
  • Meals for Corevalve Evolut R · 2023-05-19 · $27
  • Meals for Corevalve Evolut R · 2023-02-09 · $119
Boston ScientificNone$144
1 payment
  • Meals · 2023-10-24 · $144
Merck Sharp & DohmeVerquvo$100
1 payment
  • Meals for Verquvo · 2023-06-30 · $100
Abbott LaboratoriesOptis$22
1 payment
  • Meals for Optis · 2023-05-24 · $22

2022: $5,738

Payments by company in 2022
CathWorksFfrangio$4,565
3 payments
  • Consulting for Ffrangio · 2022-12-15 · $4,500
  • Meals for Ffrangio · 2022-03-03 · $25
  • Meals for Ffrangio · 2022-02-26 · $40
Siemens Medical Solutions USAAi-Rad Companion (Musculoskeletal)$570
1 payment
  • Consulting for Ai-Rad Companion (Musculoskeletal) · 2022-12-09 · $570
MedtronicCorevalve Evolut R$343
2 payments
  • Meals for Corevalve Evolut R · 2022-07-13 · $158
  • Meals for Corevalve Evolut R · 2022-03-10 · $185
Abbott LaboratoriesOptis$178
4 payments
  • Meals for Pressurewire · 2022-08-03 · $14
  • Meals for Pressurewire · 2022-08-03 · $30
  • Meals for Optis · 2022-03-17 · $35
  • Meals for Optis · 2022-03-17 · $99
Boston ScientificGeneral - Structural Heart$82
1 payment
  • Meals for General - Structural Heart · 2022-11-28 · $82

2021: $3,480

Payments by company in 2021
GentuityGentuity Hf-Oct Imaging System$1,663
1 payment
  • Consulting for Gentuity Hf-Oct Imaging System · 2021-10-15 · $1,663
ZOLL CirculationTherox Ds2 Console$900
1 payment
  • Paid to speak or teach for Therox Ds2 Console · 2021-05-06 · $900
MedtronicCorevalve Evolut$810
4 payments
  • Meals for Corevalve Evolut · 2021-11-30 · $71
  • Meals for Corevalve Evolut · 2021-11-30 · $386
  • Travel for Corevalve Evolut · 2021-11-10 · $190
  • Travel for Corevalve Evolut · 2021-11-10 · $164
Neovasc MedicalNone$75
1 payment
  • Meals · 2021-12-02 · $75
Abbott LaboratoriesPressurewire Ffr$32
1 payment
  • Meals for Pressurewire Ffr · 2021-06-21 · $32

2020: $435

Payments by company in 2020
Medtronic VascularVisia Af$194
2 payments
  • Meals for Resolute · 2020-08-18 · $18
  • Meals for Visia Af · 2020-03-03 · $177
CathWorksFfrangio System$155
1 payment
  • Meals for Ffrangio System · 2020-02-06 · $155
Acist Medical SystemsRxi Consumables$56
1 payment
  • Meals for Rxi Consumables · 2020-02-22 · $56
Boston ScientificGeneral - Structural Heart$30
1 payment
  • Meals for General - Structural Heart · 2020-02-23 · $30

2019: $30,047

Payments by company in 2019
CathWorksFfrangio System$17,942
3 payments
  • Paid to speak or teach for Ffrangio System · 2019-10-15 · $1,500
  • Travel for Ffrangio System · 2019-10-15 · $836
  • Current or prospective ownership or investment interest for Ffrangio System · 2019-07-31 · $15,606
Philips Electronics North AmericaIgt Systems Und$11,664
6 payments
  • Travel for Igt Systems Und · 2019-07-13 · $113
  • Meals for Sector Undivided · 2019-07-11 · $28
  • Meals for Sector Undivided · 2019-07-10 · $36
  • Travel for Igt Systems Und · 2019-07-10 · $113
  • Travel for Igt Systems Und · 2019-07-08 · $354
  • Travel for Igt Systems Und · 2019-06-22 · $11,021
Medtronic VascularResolute$232
3 payments
  • Meals for Corevalve Evolut · 2019-09-28 · $33
  • Meals for Resolute · 2019-09-26 · $184
  • Meals for Corevalve Evolut · 2019-03-17 · $15
Acist Medical SystemsCvi Consumables$84
1 payment
  • Meals for Cvi Consumables · 2019-10-30 · $84
Edwards LifesciencesNone$78
1 payment
  • Meals · 2019-09-23 · $78
Abbott LaboratoriesPressurewire Ffr$31
1 payment
  • Meals for Pressurewire Ffr · 2019-10-14 · $31
Boston ScientificGeneral Structural Heart$16
1 payment
  • Meals for General Structural Heart · 2019-10-30 · $16

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Medtronic Vascular, Inc. · 2019Their institution$925,000
Abbott Laboratories · Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (Fame) 3 Trial A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease · 2020Their institution$500,000
Abbott Laboratories · A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Arter · 2019Their institution$500,000
Medtronic Vascular, Inc. · 2020Their institution$500,000
Medtronic, Inc. · 2021Their institution$250,000
CathWorks, Inc. · All-Rise · 2024Their institution$209,024
CathWorks, Inc. · All-Rise · 2025Their institution$155,245
Medtronic, Inc. · Investigator Sponsored Research · 2024Their institution$122,500
Medtronic, Inc. · Investigator Sponsored Research: A 1123180.002 · 2025Their institution$52,500
Gentuity, LLC · Physio-Anatomy Clinical Data Collection · 2023Their institution$52,167
BOSTON SCIENTIFIC CORPORATION · Non Hyperemic Pressure Ratio Or Fractional Flow Reserve for Serial Coronary Lesion Assessment · 2020Their institution$50,000
Boston Scientific Corporation · Non Hyperemic Pressure Ratio Or Fractional Flow Reserve for Serial Coronary Lesion Assessment · 2021Their institution$50,000
CathWorks, Inc. · All-Rise · 2023Their institution$44,559
Abbott Laboratories · Optical Coherence Tomography (Oct) Guided Coronary Stent Implantation Compared To Angiography: A Multicenter Randomized Trial in Pci · 2019Their institution$40,816
Edwards Lifesciences Corporation · Trial 2017-18 Exceed · 2019Their institution$29,539
Abbott Laboratories · Optical Coherence Tomography (Oct) Guided Coronary Stent Implantation Compared To Angiography: A Multicenter Randomized Trial in Pci · 2020Their institution$26,693
Medtronic, Inc. · Restore · 2025Their institution$20,019
Gentuity, LLC · Physio-Anatomy Clinical Data Collection Study · 2022Their institution$19,495
Abbott Laboratories · Optical Coherence Tomography (Oct) Guided Coronary Stent Implantation Compared To Angiography: A Multicenter Randomized Trial in Pci · 2021Their institution$14,248
Abbott Laboratories · Validation of Oct-Based Fusion Study · 2022Their institution$13,554
Abbott Laboratories · Validation of Oct-Based Functional Diagnosis of Coronary Stenosis · 2021Their institution$13,207
ARENA PHARMACEUTICALS, INC. · A Phase 2 Multicenter Randomized Doubleblind Placebocontrolled Study To Assess the Safety Tolerability and Effect on Microvascular Obstruction of Temanogrel in Subjects Undergoing Percutaneous Coronary Intervention · 2022Their institution$9,406
Abbott Laboratories · Fusion · 2021Their institution$8,328
ARENA PHARMACEUTICALS, INC. · A Phase 2 Multicenter Randomized Doubleblind Placebocontrolled Study To Assess the Safety Tolerability and Effect on Microvascular Obstruction of Temanogrel in Subjects Undergoing Percutaneous Coronary Intervention · 2023Their institution$8,255
Abbott Laboratories · Evaluation of Xience Prime Everolimus Eluting Stent System (Eecss) Or Xience V Eecss Or Xience Xpedition Eecss Or Xience Pro Eecss Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization · 2019Their institution$5,438
Abbott Laboratories · Optical Coherence Tomography Guided Coronary Stent Implantation Compared To Angiography: A Multicenter Randomized Trial in Pci · 2022Their institution$4,740
Abbott Laboratories · Portico Re-Sheathable Transcatheter Aortic Valve System US Ide Trial (Portico) · 2020Their institution$4,086
Abbott Laboratories · Portico Re-Sheathable Transcatheter Aortic Valve System US Ide Trial (Portico) · 2021Their institution$3,350
Gentuity, LLC · Physio-Anatomy Data Collection · 2024Their institution$3,000
Edwards Lifesciences Corporation · Trial #2017-18 Exceed · 2020Their institution$2,346
Abbott Laboratories · Optical Coherence Tomography (Oct) Guided Coronary Stent Implantation Compared To Angiography: A Multicenter Randomized Trial in Pci · 2023Their institution$1,850
Abbott Laboratories · Ilumien IV: Optimal Pci · 2020Their institution$1,778
Abbott Laboratories · Portico Re-Sheathable Transcatheter Aortic Valve System US Ide Trial (Portico) · 2022Their institution$38

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1770671455
Licence
CA A54553California A54553: Current · expires 2029-01-31
Trained
Columbia University College of Physicians and Surgeons, 1994
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-10-10
NPI last updated
2024-04-15
NPI record certified
2024-04-15

This is when the NPI record was last certified, not a medical board exam.